Pfizer (PFE) has been on a downward spiral lately with significant selling pressure. After declining 11% over the past four ...

NEW YORK (Reuters) - Pfizer (NYSE:PFE) is exploring the sale of its hospital drugs unit, as the drugmaker, which has been ...

Jefferies analyst Akash Tewari maintained a Buy rating on Pfizer (PFE – Research Report) today and set a price target of $33.00 ... corporate insider sentiment is neutral on the stock. Last month, ...

On Friday, Pfizer Inc (PFE) stock saw a decline, ending the day at $26.72 which represents a decrease of $-0.74 or -2.69% from the prior close of $27.46. The stock opened at $27.11 and touched a low ...

Pfizer, a multinational pharmaceutical and biotechnology corporation, is now a $159 billion (by market cap) healthcare giant.

More than a few companies that did well in the past are out of favor with investors. And that could spell opportunity.

We recently compiled a list of the 10 Best Low Volatility Stocks to Invest in Now. In this article, we are going to take a ...

On Thursday, Pfizer Inc (PFE) stock saw a modest uptick, ending the day at $27.46 which represents a slight increase of $0.10 or 0.37% from the prior close of $27.36. The stock opened at $27.53 and ...

But making Pfizer Inc an even more interesting and timely stock to look at, is the fact that in trading on Friday, shares of ...

Analysis of Pfizer's financial performance, acquisitions, and future prospects, highlighting key challenges and opportunities ...

One stock yields 6% today. Another has grown its dividend by 460% over the past decade. Both are blue chip bargains to buy ...

Pfizer has a pill it's developing called danuglipron, which is in early-stage trials but has demonstrated that it's ...